Frank Weber
Fortuna: 232 291 $ al 31/07/2026
Fortuna: 232 291 $ al 31/07/2026
Dr. Frank T.
Weber, MD, is a CEO, Executive Director & Chief Medical Officer at Vivoryon Therapeutics NV.
He is on the Board of Directors at Vivoryon Therapeutics NV and Zambon Biotech SA. Dr. Weber was previously employed as a Chief Medical & Development Officer by Spexis Ltd., a Senior Vice President-European Medical Division by InterMune International AG, a Medical Director by MedNet GmbH, a Chief Medical Officer by Merck KGaA, and a Chief Medical Officer by Merck Serono SA. He received his doctorate degree from Universität zu Köln.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 17/04/2026 | 168.950 ( 0,57 % ) | 232 291 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| VIVORYON THERAPEUTICS N.V. | Director Ejecutivo | 14/08/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
| MERCK KGAA | Director Técnico/Científico/I+D | - |
InterMune International AG
InterMune International AG Miscellaneous Commercial ServicesCommercial Services Leases nonfinancial intangible assets | Corporate Officer/Principal | - |
Merck Serono SA
Merck Serono SA Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for reproductive and metabolism | Director Técnico/Científico/I+D | - |
MedNet GmbH
MedNet GmbH Medical DistributorsDistribution Services Wholesales medical devices and semi-finished products | Corporate Officer/Principal | - |
| SPEXIS AG | Director Técnico/Científico/I+D | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 7 |
|---|---|
Merck KGaA
Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Universität zu Köln
Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spexis Ltd.
Spexis Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that focuses on the discovery and development of macrocycle drugs addressing unmet medical needs | Health Technology |
Merck Serono SA
Merck Serono SA Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for reproductive and metabolism | Health Technology |
Vivoryon Therapeutics NV
Vivoryon Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that is engaged in the research and development of new therapeutic products for the treatment of Alzheimer disease | Commercial Services |
MedNet GmbH
MedNet GmbH Medical DistributorsDistribution Services Wholesales medical devices and semi-finished products | Distribution Services |
InterMune International AG
InterMune International AG Miscellaneous Commercial ServicesCommercial Services Leases nonfinancial intangible assets | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.